Delivery Order SPE2DB20D2014-SPE2DB25FC63Y
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,715.83 on July 29, 2025, for the supply of Fluticasone Propionate HFA 44 microgram inhalers (10.6 grams). This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order valued at $1,498.25 to AmerisourceBergen Drug Corp for the supply of Fluticasone Propionate HFA 110 micrograms in a 12-gram inhaler. This firm fixed price contract, issued on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers, with a contract value of $24,494.88 and an ultimate completion date of July 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued as a competitive award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $2,532.00 delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 220 mcg inhalers (12 grams). This competitively awarded, firm fixed-price delivery order was issued on August 19, 2025, with an ultimate completion date of August 20, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract represents a standard pharmaceutical procurement under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $3,824.58 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 microgram inhalers (12 gram units) on August 6, 2025, with an ultimate completion date of August 7, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency awarded a delivery order valued at $2,436.13 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers. This contract, issued on August 25, 2025, with completion scheduled for August 26, 2025, utilizes firm fixed pricing and represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and primary distribution center...
- The Defense Logistics Agency awarded a delivery order valued at $2,108.90 to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Fluticasone Propionate HFA 110 mcg inhalers (12 grams), with an ultimate completion date of July 15, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction under AmerisourceBergen's existing contract vehicle with DLA. The product will be delivered to the company's location in Conshohocken, Pennsylvania,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers. This is a firm fixed-price, non-set-aside contract with a ceiling value of $1,051.91 and an ultimate completion date of August 15, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's...
- The Defense Logistics Agency awarded a $4,557.00 delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 mcg inhalers (12 grams) on July 17, 2025, with an ultimate completion date of July 18, 2025. This is a firm fixed-price, non-set-aside contract performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $4,436.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 44 micrograms in 10.6-gram inhalers. The award, issued on May 30, 2025, with an ultimate completion date of June 2, 2025, represents a non-set-aside competitive procurement. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's larger Indefinite...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC63YDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $42,827.06 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 microgram inhalers (12-gram units) on August 4, 2025, with completion scheduled for August 5, 2025. This firm fixed-price delivery order represents a non-set-aside award issued under competitive procedures. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a ceiling value of $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp serves as a primary pharmaceutical distributor for the federal government's military and veteran healthcare systems through its comprehensive IDC vehicle with the Defense Logistics Agency. The company's role under the SPE2DX contract encompasses the supply of a broad range of pharmaceutical products, medical supplies, vaccines, and specialty medications to support Defense Health Agency operations and other federal healthcare customers. This specific delivery order for Fluticasone Propionate inhalers reflects the company's ongoing role in fulfilling respiratory medication needs across military healthcare programs. The competitive award demonstrates AmerisourceBergen's continued capability to meet federal procurement standards and support the Department of Defense's pharmaceutical supply chain requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $42.8k | 8/4/25 |